Gevo, Inc. has announced the sale of approximately $20 million in Investment Tax Credits to an undisclosed corporate buyer.
Obesity-focused biotech BioAge Labs said on Wednesday it was seeking a valuation of as much as $587 million in its initial ...
Obesity-focused biotech BioAge Labs said on Wednesday it was seeking a valuation of as much as $587 million in its initial public offering in the United States, according to a regulatory filing.